Showing 1881-1890 of 2715 results for "".
- Gryphon Investors Signs Deal to Aquire Revision Skincarehttps://modernaesthetics.com/news/gryphon-investors-signs-deal-to-aquire-revision-skincare/2473163/The Middle-market private equity firm Gryphon Investors has signed a definitive agreement to acquire Revision Skincare and Goodier Cosmetics, with an anticipating closing date this year. Financial terms of the transaction were not disclosed. Revision Goodier's management team
- Crown Aesthetics Announces SkinPen Precision Ambassador Program in Celebration Of National Microneedling Dayhttps://modernaesthetics.com/news/crown-aesthetics-announces-skinpen-precision-ambassador-program-in-celebration-of-national-microneedling-day/2473156/Crown Aesthetics announced the launch of their SkinPen Ambassador Program in conjunction with National Microneedling Day. The SkinPen Ambassador Program presents current SkinPen providers with the opportunity to showcase their practice success and to share valuable insights and SkinPen
- Congrats: Dr. Corey S. Maas Named New AAFPRS Presidenthttps://modernaesthetics.com/news/congrats-dr-corey-s-maas-named-new-aafprs-president/2473155/Corey S. Maas, MD is the new president of the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS). Dr. Mass, the founder of The Maas Clinic in San Francisco, will serve the 2021 to 2022 year term Dr. Maas is certified
- Alastin Launches Sensitive Skincare Collectionhttps://modernaesthetics.com/news/alastin-launches-sensitive-skincare-collection/2473154/Alastin’s new sensitive skin collection has launched with three sensitive skincare products: Ultra Calm Cleansing Cream, Ultra Light Moisturizer with TriHex Technology® and SilkSHIELD All-Mineral Sunscreen SPF 30 with TriHex Technology®. The collection includes ultra-calming, restor
- Allergan Aesthetics’ New Power of You Campaign Supports Breast Cancer Awarenesshttps://modernaesthetics.com/news/allergan-aesthetics-new-power-of-you-campaign-supports-breast-cancer-awareness/2473152/Allergan Aesthetics’ Power of You campaign is kicking off a new series of initiatives and partnerships to support breast cancer awareness. The Power of You campaign showcases real women and their authentic stories of courage, strength, and community as they embark on th
- ASDSA Applauds FDA for Safety Communication on Needle-less Injector Deviceshttps://modernaesthetics.com/news/asdsa-applauds-fda-for-safety-communication-on-needle-less-injector-devices/2473151/The American Society for Dermatologic Surgery Association (ASDSA) applauds the U.S. Food and Drug Administration (FDA) for sending out a safety communication regarding needle-less devices, such as hyaluron p
- Aesthetics Biomedical, US Dermatology Partners Enter Long-term Partnershiphttps://modernaesthetics.com/news/aesthetics-biomedical-us-dermatology-partners-enter-long-term-partnership/2473150/Aesthetics Biomedical® Inc. is entering a long-term partnership with U.S. Dermatology Partners, the largest physician-led dermatology practice in the US, to bring Vivace procedures and ther
- Alastin Receives Two New Patents for Technology Related to TransFORM Body Treatmenthttps://modernaesthetics.com/news/alastin-receives-two-new-patents-for-technology-related-to-transform-body-treatment/2473148/With the issuance of two new patents from the United States Patent and Trademark Office, Alastin Skincare, Inc. now holds six patents in the US, along with a seventh patent issued in Canada. US Patent No.11,052,032 covers Alastin’s
- New Hydrafacial, Epicutis Collab: Epicutis’ Neck & Décoletté Boosterhttps://modernaesthetics.com/news/new-hydrafacial-epicutis-collab-epicutis-neck-decolette-booster/2473144/HydraFacial is partnering with Epicutis to offer a new booster: Epicutis’ Neck & Décoletté Booster. Epicutis’ Neck & Décoletté Booster aims to reduce the wrinkled appearance of the face and neck, combat the appearance of fine lines and wri
- It’s Over: AbbVie, BTL Settle Muscle Stimulation Patent Disputehttps://modernaesthetics.com/news/its-over-abbvie-btl-settle-patent-dispute/2473143/BTL Industries has resolved its patent infringement claims against AbbVie related to BTL's muscle stimulation technology. Under the terms of the settlement agreement, AbbVie will pay BTL an undisclosed payment. The details of the agreement are confidential and will not be disc